What the Price Implies

What the Price Implies

At $142.14, Accenture trades at about 11.7x trailing and 10.3x forward earnings — roughly a third of the ~30x it commanded through 2021–2024, and below every offshore peer in its own filings. Backed out through a simple discount model, that multiple embeds close to zero perpetual growth in earnings and cash flow. At that level, the price implies low-single-digit growth is the start of a decline rather than a floor.

Sources: price and consensus per market data as of 7 Jul 2026; FY2025 GAAP diluted EPS of $12.15 and cash dividend of $5.92 per share [1]; FY2026 adjusted EPS guidance of $13.78–$13.90 [2]; FCF yield derived from SBC-adjusted free cash flow of ~$8.8B on a ~$89.9B market capitalization.

The forward multiple is unambiguous. Full-year fiscal 2026 GAAP diluted EPS is guided to $13.38–$13.50 and adjusted EPS to $13.78–$13.90 [3]. Against the $142.14 close that is 10.6x on the GAAP midpoint and 10.3x on the adjusted midpoint. On the ~$8.8 billion of free cash flow that survives the $2.1 billion share-based-compensation add-back examined in Cash and Compounding, the free-cash-flow yield is ~9.8%; on the $10.9 billion headline figure it is ~12.1%. Either way, a 25%-return-on-equity, net-cash business is priced at a yield most investors associate with no-growth cyclicals.

A de-rating, not a drawdown

The compression happened in two stages. Through fiscal 2020–2025 the share price simply went nowhere while the market compounded: $100 invested in Accenture on 31 August 2020 was worth $117 five years later, against $199 for the S&P 500 and $251 for the S&P 500 IT sector [4]. The stock peaked in the index at $151 in fiscal 2024 and gave it all back by fiscal 2025.

Source: FY2025 Annual Report, Comparison of Cumulative Total Return [5].

The second stage came after the fiscal year closed. The stock fell roughly 50% across calendar 2026, including a record single-day decline of about 18% on 18 June 2026 — the day Accenture cut full-year revenue-growth guidance to 3–4% in local currency [6], down from the 3–5% range set in March [7], and analysts recast the story around AI disrupting the labor-based model. The multiple, near 37x at its 2021 peak and averaging roughly 26x over the past decade per market data, now sits near 11x — its lowest as a public company. The market has repriced Accenture from a secular grower to a mature services firm.

Priced below its own peer set

The starkest evidence that this is a re-rating rather than a sector move is relative. Accenture is two to three times the size of any pure-play peer and, as Moat and Disintermediation set out, the entrenched leader of the group — yet it trades below the offshore Indian majors on trailing earnings and roughly in line with the two Western pure-plays whose growth has stalled.

Source: derived from each company's latest reported net income and market capitalization per market data. Accenture's FY2025 10-K describes its competitors as large multinational IT service providers and India-based offshore providers [8]; the multinational and offshore majors shown are the standard named comparables. IBM is excluded because its ~27x group multiple reflects a software-heavy mix, not a comparable services business.

This inversion is new. Accenture historically traded at a premium to all of these names, and to the market. Today TCS (15.3x) and Infosys (14.7x) — structurally more profitable per dollar, as Moat and Disintermediation quantified — carry higher multiples, while Cognizant (9.3x) and Capgemini (9.7x), both wrestling with weak growth, anchor the bottom. Accenture sits with the laggards. That is either a mispricing of the franchise leader or the market's judgment that scale no longer confers a premium in an AI-disrupted services market.

What the multiple embeds

Reversing the arithmetic gives the cleanest read on expectations. Treating adjusted EPS as a proxy for distributable cash — reasonable for a business that spends under 1% of revenue on capital — and discounting at a 9% cost of equity, a fair multiple of 1 ÷ (r − g) implies the perpetual growth rate the price is paying for. At $142, the embedded growth is roughly zero; at the $179 consensus target it is about 1–2%; the decade-average 26x multiple embedded around 5%.

Source: derived — fair P/E = 1 ÷ (9% − g), applied to the $13.84 midpoint of FY2026 adjusted EPS guidance [9]. Illustrative; sensitive to the discount rate assumed.

The exercise is a simplification — it assumes a single discount rate and treats adjusted earnings as fully distributable — but the direction is robust across reasonable inputs: at today's price the market is paying for a business whose free cash flow never grows again, and may gently decline. That is a coherent position given the disclosed disintermediation risk, falling bookings (Q3 FY2026 new bookings of $19.3 billion were down 3% in local currency [10]), and the roughly flat organic growth documented in Cash and Compounding. It is also a demanding one: management is guiding to 7–8% adjusted EPS growth for fiscal 2026 [11], and the company still returns roughly $9.5 billion a year to shareholders while holding net cash.

The gap between price and consensus

The evidence points to a stock priced for structural decline in a business still growing earnings and cash. Which reading wins turns on the trajectory of organic bookings and revenue rather than on the multiple itself, and the two paths — the arithmetic bull case that needs no re-rating and the bear case that reads the low multiple as information — are laid out with their monitorable signals in Scenarios and Signals.

For valuation purposes the point is narrower. At roughly 10x forward earnings the price already embeds close to zero perpetual growth, so the ~26% gap to the ~$179 consensus target is best read not as obvious upside but as the market's honest disagreement about which growth regime Accenture is in.